Literature DB >> 2552650

Evaluation of immunity to feline infectious peritonitis in cats with cutaneous viral-induced delayed hypersensitivity.

R C Weiss1, N R Cox.   

Abstract

Delayed-type hypersensitivity (DTH)-like reactions to feline infectious peritonitis (FIP) virus (FIPV) were induced in the skin of nine cats that were asymptomatic after a previous challenge-exposure with FIPV. Four of the nine previously challenge-exposed cats were negative for virus-neutralizing antibodies against FIPV at the time of intradermal (ID) testing for DTH. Two other cats tested for DTH when acutely ill with clinical FIP did not have cutaneous DTH responses to FIPV. Gross skin reactions to FIPV injected ID were observed in six of nine asymptomatic cats (67%) at postintradermal inoculation hours (PIH) 24, 48, and/or 72. The reactions consisted of focal, 1-5-mm to 2.5-cm diameter indurated or semi-firm, nonerythematous, slightly raised nodules. Microscopically, DTH-like reactions were observed in biopsies taken from the FIPV-inoculated skin of asymptomatic cats at PIH 24 to 72. The lesions consisted of perivascular and diffuse dermal infiltrations by macrophages, lymphocytes, and polymorphonuclear leukocytes (PMN). The dermal infiltrates, which were maximal at PIH 48 or 72, were predominantly mixed inflammatory cells (five of nine cats) or PMN (four of nine cats) at PIH 24, but later were predominantly mononuclear cells (six of nine cats) or mixed inflammatory cells (two of nine cats) at PIH 72. Five of nine cats (56%) with positive DTH skin responses had increased survival times after lethal ID challenge-exposure with FIPV compared to mean survival times in FIPV-naive, non-immune control cats that were DTH-negative when ID challenge-exposed. Four of nine DTH-positive cats (44%) resisted an ID challenge-exposure dose of FIPV that was fatal in both control cats, and two of the four remaining DTH-positive cats survived a third challenge-exposure with highly lethal doses of FIPV given intraperitoneally. Four of the six DTH-positive cats (67%) that died after re-challenge and were necropsied had lesions of noneffusive FIP, suggesting that cellular immunity may also be involved in the pathogenesis of noneffusive disease, whereas both control cats and both DTH-negative cats with clinical disease succumbed to effusive FIP. Seemingly, DTH responses to FIPV can be associated with an increased level of resistance to disease; however, this state of immunity is variable and apparently can be lost with time in some cats.

Entities:  

Mesh:

Year:  1989        PMID: 2552650      PMCID: PMC7133611          DOI: 10.1016/0165-2427(89)90038-x

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  22 in total

1.  The Arthus reaction in domestic cats.

Authors:  A B Kier; J J McDonnell; A Stern; M C McNutt
Journal:  Vet Immunol Immunopathol       Date:  1988-04       Impact factor: 2.046

Review 2.  Immunopathology induced by the feline leukemia virus.

Authors:  W D Hardy
Journal:  Springer Semin Immunopathol       Date:  1982

3.  Pathogenesis of feline infectious peritonitis: nature and development of viremia.

Authors:  R C Weiss; F W Scott
Journal:  Am J Vet Res       Date:  1981-03       Impact factor: 1.156

4.  Immunologic phenomena in the effusive form of feline infectious peritonitis.

Authors:  N C Petersen; J F Boyle
Journal:  Am J Vet Res       Date:  1980-06       Impact factor: 1.156

5.  Delayed hypersensitivity in the mouse.

Authors:  A J Crowle
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

6.  Pathology of non-effusive type feline infectious peritonitis and experimental transmission.

Authors:  T Hayashi; F Utsumi; R Takahashi; K Fujiwara
Journal:  Nihon Juigaku Zasshi       Date:  1980-04

7.  Attempted immunization of cats against feline infectious peritonitis, using avirulent live virus or sublethal amounts of virulent virus.

Authors:  N C Pedersen; J W Black
Journal:  Am J Vet Res       Date:  1983-02       Impact factor: 1.156

8.  Chemically-induced delayed hypersensitivity in the cat.

Authors:  K T Schultz; H C Maguire
Journal:  Vet Immunol Immunopathol       Date:  1982-11       Impact factor: 2.046

9.  In vivo and in vitro responses of cats sensitized with viable Mycobacterium bovis (BCG).

Authors:  A M Legendre; J R Easley; P U Becker
Journal:  Am J Vet Res       Date:  1979-11       Impact factor: 1.156

10.  Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever.

Authors:  R C Weiss; F W Scott
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1981       Impact factor: 2.268

View more
  14 in total

1.  Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease.

Authors:  Jolanda D F de Groot-Mijnes; Jessica M van Dun; Robbert G van der Most; Raoul J de Groot
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Chimeric feline coronaviruses that encode type II spike protein on type I genetic background display accelerated viral growth and altered receptor usage.

Authors:  Gergely Tekes; Regina Hofmann-Lehmann; Barbara Bank-Wolf; Reinhard Maier; Heinz-Jürgen Thiel; Volker Thiel
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

3.  Absence of surface expression of feline infectious peritonitis virus (FIPV) antigens on infected cells isolated from cats with FIP.

Authors:  E Cornelissen; H L Dewerchin; E Van Hamme; H J Nauwynck
Journal:  Vet Microbiol       Date:  2006-12-02       Impact factor: 3.293

4.  Mucosal Immune Response to Feline Enteric Coronavirus Infection.

Authors:  Morgan Pearson; Alora LaVoy; Samantha Evans; Allison Vilander; Craig Webb; Barbara Graham; Esther Musselman; Jonathan LeCureux; Sue VandeWoude; Gregg A Dean
Journal:  Viruses       Date:  2019-09-27       Impact factor: 5.048

5.  Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in the spike 2 domain and the nucleocapsid protein of feline infectious peritonitis virus.

Authors:  Ryoichi Satoh; Tomoko Furukawa; Masako Kotake; Tomomi Takano; Kenji Motokawa; Tsuyoshi Gemma; Rie Watanabe; Setsuo Arai; Tsutomu Hohdatsu
Journal:  Vaccine       Date:  2011-01-07       Impact factor: 3.641

6.  Effect of recombinant human interferon-alpha in vitro and in vivo on mitogen-induced lymphocyte blastogenesis in cats.

Authors:  R C Weiss; T Oostrom-Ram
Journal:  Vet Immunol Immunopathol       Date:  1990-02       Impact factor: 2.046

7.  Placebo-controlled evaluation of a modified life virus vaccine against feline infectious peritonitis: safety and efficacy under field conditions.

Authors:  D Fehr; E Holznagel; S Bolla; B Hauser; A A Herrewegh; M C Horzinek; H Lutz
Journal:  Vaccine       Date:  1997-07       Impact factor: 3.641

8.  Characterization of peritoneal cells from cats with experimentally-induced feline infectious peritonitis (FIP) using RNA-seq.

Authors:  Rie Watanabe; Christina Eckstrand; Hongwei Liu; Niels C Pedersen
Journal:  Vet Res       Date:  2018-08-07       Impact factor: 3.683

Review 9.  Feline immune system.

Authors:  D S Lin
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1992-01       Impact factor: 2.268

Review 10.  Coronaviridae, pathogenetic and clinical aspects: an update.

Authors:  K Möstl
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1990       Impact factor: 2.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.